Osaic Holdings’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.5K Buy
124
+30
+32% +$9.5K ﹤0.01% 5610
2026
Q1
$30.3K Buy
94
+11
+13% +$3.4K ﹤0.01% 5569
2025
Q4
$24.5K Buy
83
+3
+4% +$559 ﹤0.01% 5738
2025
Q3
$4.16K Buy
80
+26
+48% +$1.26K ﹤0.01% 6852
2025
Q2
$2.27K Sell
54
-12
-18% -$457 ﹤0.01% 6890
2025
Q1
$2.5K Sell
66
-13
-16% -$812 ﹤0.01% 6508
2024
Q4
$6.08K Buy
79
+18
+30% +$1.3K ﹤0.01% 6083
2024
Q3
$3.51K Buy
61
+22
+56% +$1.19K ﹤0.01% 6379
2024
Q2
$1.61K Buy
+39
New +$1.84K ﹤0.01% 6675
2022
Q4
Sell
-12
Closed 7375
2022
Q3
$0 Buy
+12
New +$598 ﹤0.01% 7450

Other funds holding PRAX

Osaic Holdings's PRAX Position: Q2 2026 in Review

Osaic Holdings increased its Praxis Precision Medicines (PRAX) stake by 32% in Q2 2026, buying an estimated $9.5K and bringing the position to 124 shares worth $41.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5610.

Osaic Holdings first reported a position in PRAX in Q3 2022 and has held it in 10 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Osaic Holdings held 124 shares of Praxis Precision Medicines worth $41.5K as of Q2 2026.
  • Osaic Holdings bought 30 Praxis Precision Medicines shares in Q2 2026, an estimated $9.5K.
  • Praxis Precision Medicines made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5610 holding.
  • Osaic Holdings first reported a position in Praxis Precision Medicines in Q3 2022 and has held it in 10 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.